Data gathered: June 18
AI Stock Analysis - Vertex (VERX)
Analysis generated July 28, 2024. Powered by Chat GPT.
Vertex Pharmaceuticals Inc. is a global biotechnology company that engages primarily in the discovery, advancement, and commercialization of innovative therapies. The company focuses on serious diseases where there is a need for medical breakthroughs. Vertex is well-known for its work in cystic fibrosis and is exploring new areas such as pain, sickle cell disease, and beta-thalassemia. The company’s significant investment in R&D highlights its commitment to medical advancements and long-term growth potential.
Stock Alerts - Vertex (VERX)
 |
Vertex | June 10 Over the past few months, there has been an downward trend in Web Traffic. |
|
Vertex | June 10 Price is down by -7.2% in the last 24h. |
|
Vertex | May 17 AI Score is down by 20.2% in the last couple of days. |
|
Vertex | May 15 Insider Alert: DeStefano David is selling shares |
Download our app to get future alerts delivered in real-time.
Alternative Data for Vertex
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 127 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 86,000 | Sign up | Sign up | Sign up |
| Employee Rating | 82 | Sign up | Sign up | Sign up |
| Google Trends | 55 | Sign up | Sign up | Sign up |
| Patents | 7 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 2 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,495 | Sign up | Sign up | Sign up |
| Instagram Followers | 912 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 402 | Sign up | Sign up | Sign up |
| Twitter Followers | 4,930 | Sign up | Sign up | Sign up |
| Twitter Mentions | 120 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 3,230 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 88 | Sign up | Sign up | Sign up |
| Linkedin Employees | 2,515 | Sign up | Sign up | Sign up |
About Vertex
Vertex, Inc. provides tax technology solutions for retail, communication, leasing, retail trade, wholesale trade, technology, and manufacturing industries in the United States and internationally.
| Price | $36.41 |
| Target Price | Sign up |
| Volume | 97,620 |
| Market Cap | $5.85B |
| Year Range | $31.15 - $58.95 |
| Dividend Yield | 0% |
| PE Ratio | 224.37 |
| Analyst Rating | 56% buy |
| Industry | Application Software |
In the news
 |
Returns On Capital Are Showing Encouraging Signs At Vertex (NASDAQ:VERX)June 16 - Yahoo |
 |
Vertex, Inc. (NASDAQ:VERX) Receives $50.73 Consensus Price Target from AnalystsJune 11 - ETF Daily News |
 |
Vertex: Expensive, Losing Customers, And Shedding Margins (Downgrade)June 11 - SeekingAlpha |
 |
QuantumBlack meets Vertex AI: Solving healthcare’s data usability challenge with AIJune 11 - SiliconANGLE News |
 |
514 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Purchased by OLD National Bancorp INJune 11 - ETF Daily News |
 |
$1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much TodayJune 10 - Biztoc.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 177M | 64M | 113M | 11M | 0 | 0.000 |
| Q4 '24 | 178M | 61M | 117M | -68M | 27M | 0.150 |
| Q3 '24 | 170M | 60M | 111M | 7.2M | 10M | 0.160 |
| Q2 '24 | 161M | 65M | 96M | 5.2M | 29M | 0.150 |
| Q1 '24 | 157M | 61M | 96M | 2.7M | 20M | 0.150 |
Insider Transactions View All
| DeStefano David filed to sell 1,125,431 shares at $37.3. May 14 '25 |
| DeStefano David filed to sell 1,066,587 shares at $38.1. May 14 '25 |
| DeStefano David filed to sell 989,411 shares at $38.7. May 14 '25 |
| DeStefano David filed to sell 997,712 shares at $37.8. May 14 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
MicrosoftMSFT |
$479.4 0.3% | 38 |
 |
OracleORCL |
$212.16 1.9% | 52 |
 |
AdobeADBE |
$382.87 0% | 47 |
 |
IntuitINTU |
$754.87 1.3% | 59 |
 |
AutodeskADSK |
$296.24 0.2% | 54 |
Read more about Vertex (VERX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Vertex?
The Market Cap of Vertex is $5.85B.
What is Vertex's PE Ratio?
As of today, Vertex's PE (Price to Earnings) ratio is 224.37.
What is the current stock price of Vertex?
Currently, the price of one share of Vertex stock is $36.41.
How can I analyze the VERX stock price chart for investment decisions?
The VERX stock price chart above provides a comprehensive visual representation of Vertex's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Vertex shares. Our platform offers an up-to-date VERX stock price chart, along with technical data analysis and alternative data insights.
Does VERX offer dividends to its shareholders?
As of our latest update, Vertex (VERX) does not offer dividends to its shareholders. Investors interested in Vertex should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Vertex?
Some of the similar stocks of Vertex are Microsoft, Oracle, Adobe, Intuit, and Autodesk.
.